4.5 Article

Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00210.2013

关键词

fibrosis; inflammation; type II pneumocytes

资金

  1. Training Grant in Inflammatory and Fibrosing Diseases National Institutes of Health (NIH) [T32-AR-050958]
  2. NIH [R21-AT-004450, R01-AR-062078, R03-AR-056767, K01-AR-054143, P20-RR-016434, P20-RR-016434-09S2, P20-RR-021949]
  3. SCTR
  4. Scleroderma Foundation
  5. Leducq Foundation
  6. [USARMY/USAMRAA W81XWH-11-1-0508]

向作者/读者索取更多资源

The interstitial lung diseases (ILD) include a large number of chronic, progressive, irreversible respiratory disorders involving pulmonary fibrosis, the most common of which are idiopathic pulmonary fibrosis and scleroderma lung disease (SSc ILD). Because bleomycin causes lung fibrosis when used in cancer chemotherapy, it is used to model human ILD in rodents. In most studies, bleomycin has been delivered directly into the lung by intratracheal or intraoral administration. Here we have compared the effects in mice of bleomycin delivered directly into the lungs (direct model) or systemically using osmotic mini-pumps (pump model) to determine which more closely resembles human ILD. The pump model is more similar to human SSc ILD in that: 1) lung injury/fibrosis is limited to the subpleural portion of the lung in the pump model and in SSc ILD, whereas the entire lung is affected in the direct model; 2) conversely, there is massive inflammation throughout the lung in the direct model, whereas inflammation is limited in the pump model and in SSc ILD; 3) hypertrophic type II alveolar epithelial cells are present at high levels in SSc ILD and in the pump model but not in the direct model; and 4) lung fibrosis is accompanied by dermal fibrosis. The pump model is also move convenient and humane than the direct model because there is less weight loss and mortality.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据